Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas
Neuroradiology · 2026
DOI: 10.1007/s00234-026-03949-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroradiology, 2026. Verfasst von Chihhsuan Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Science and Technology Projects in Guangzhou, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
PURPOSE: To evaluate the diagnostic efficacy of time-dependent diffusion MRI (td-dMRI)-based cell size imaging to distinguish gliomas with different isocitrate dehydrogenase (IDH) genotypes from lung cancer or breast cancer brain metastases (BrMs). METHODS: 86 patients (29 males; mean age, 52.52 ± 12.12 years), including 21 patients with isocitrate dehydrogenase (IDH)-wildtype gliomas, 10 with IDH-mutant gliomas, 33 with breast cancer BrMs, and 22 with non‑small cell lung cancer (NSCLC) BrMs, were prospectively recruited for td-dMRI examinations. Microstructural parameters of the contrast-enhancing tumor and peritumoral edema, including mean cell diameter (C_d), volume fraction of the intracellular space (Vin), extracellular diffusivity, and cellularity, were estimated from td-dMRI using the IMPULSED model and compared across different tumors. Diagnostic performance was assessed using the area under the receiver operating characteristic curve (AUC). The microstructural parameters were validated with pathologic measurements. RESULTS: The contrast-enhancing tumor regions of NSCLC BrMs had significantly higher C_d and Vin values compared with those of IDH-wildtype gliomas, IDH-mutant gliomas, and breast cancer BrMs (P 0.05). No significant differences were found in all parameters in the peritumoral edema region (P > 0.05). C_d correlated well with pathologically average cell diameter (P = 0.013, r = 0.770) and total cell area (P = 0.039, r = 0.673) of brain tumors. CONCLUSION: td-dMRI-based microstructural imaging can be used to distinguish NSCLC BrMs from gliomas and from breast cancer BrMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Division of Medicine, University College London, London, United Kingdom.
- Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Research & Clinical Transition, Siemens Healthineers AG, Erlangen, Germany.
- MR Research Collaboration Team, Diagnostic Imaging, Siemens Healthineers Ltd, Shanghai, China.
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. tangym26@mail2.sysu.edu.cn.
Förderung
- Science and Technology Projects in Guangzhou
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Hu, C., Yang, R., Yan, Z., Shen, M., Li, B., Li, J., Chen, R., Feiweier, T., Yan, X., Wang, M., Qin, H., Tang, Y., & Mao, J. (2026). Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas. Neuroradiology. https://doi.org/10.1007/s00234-026-03949-2
Vancouver
Hu C, Yang R, Yan Z, Shen M, Li B, Li J, et al. Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas. Neuroradiology. 2026. doi:10.1007/s00234-026-03949-2
BibTeX
@article{Hu2026,
author = {Hu, Chihhsuan and Yang, Ruichen and Yan, Zhuoheng and Shen, Minxi and Li, Baoxun and Li, Jianing and Chen, Rui and Feiweier, Thorsten and Yan, Xu and Wang, Mengzhu and Qin, Haodong and Tang, Yingmei and Mao, Jiaji},
title = {Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas},
journal = {Neuroradiology},
year = {2026},
doi = {10.1007/s00234-026-03949-2}
}
EUVIMED